Codexis (CDXS) Operating Income Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Codexis | 251.43 Mn | 186.29 Mn | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.56% |
| Dec 31, 2025 | 36.22% |
| Sep 30, 2025 | -25.59% |
| Jun 30, 2025 | -16.06% |
| Mar 31, 2025 | -21.22% |
| Dec 31, 2024 | -50.62% |
| Sep 30, 2024 | -131.11% |
| Jun 30, 2024 | -27.97% |
| Mar 31, 2024 | -17.81% |
| Dec 31, 2023 | 19.49% |
| Sep 30, 2023 | -72.39% |
| Jun 30, 2023 | -26.89% |
| Mar 31, 2023 | -38.13% |
| Dec 31, 2022 | -76.35% |
| Sep 30, 2022 | -1.17% |
| Jun 30, 2022 | 16.26% |
| Mar 31, 2022 | -2.32% |
| Dec 31, 2021 | -14.62% |
| Sep 30, 2021 | -1.27% |
| Jun 30, 2021 | -31.92% |
| Mar 31, 2021 | -5.57% |
| Dec 31, 2020 | -11.94% |
| Sep 30, 2020 | -25.11% |
| Jun 30, 2020 | -1.40% |
| Mar 31, 2020 | -7.20% |
| Dec 31, 2019 | -32.60% |
| Sep 30, 2019 | 15.56% |
| Jun 30, 2019 | 5.76% |
| Mar 31, 2019 | 3.91% |
| Dec 31, 2018 | 42.05% |
| Sep 30, 2018 | 25.56% |
| Jun 30, 2018 | 20.97% |
| Mar 31, 2018 | 13.34% |
| Dec 31, 2017 | 15.50% |
| Sep 30, 2017 | -36.01% |
| Jun 30, 2017 | -3.41% |
| Mar 31, 2017 | -0.62% |
| Dec 31, 2016 | -1.37% |
| Sep 30, 2016 | 21.13% |
| Jun 30, 2016 | 19.38% |
| Mar 31, 2016 | -15.62% |
| Dec 31, 2015 | -48.14% |
| Sep 30, 2015 | 33.95% |
| Jun 30, 2015 | -11.88% |